Biotech industry regret for IPR process in AIA is building as new reform stalls and unintended consequences mount

The biotechnology and pharmaceutical industry reluctantly admits that its best intellectual property minds somehow missed the arbitrage business opportunity created by the inter partes review process under the America Invents Act of 2011. As a result, the industry today finds itself in the crosshairs of a new emerging investment strategy, a predicament that underscores the [...]

By | October 31st, 2015|Patent Investing, Patent Trolling|Comments Off on Biotech industry regret for IPR process in AIA is building as new reform stalls and unintended consequences mount

(Update3) InterDigital 3rd Qtr profit nearly doubles on higher recurring licensing revenue lower expenses

InterDigital Inc. (IDCC), the licensing company run by CEO William Merritt, said its third quarter net income almost doubled driven by higher than expected patent licensing revenue and lower patent administrative and lower litigation expenses. The Wilmington, Delaware-based company said its third quarter net income rose to $24.5million, or 68 cents a share, from $13.5 [...]

By | October 30th, 2015|Patent Investing|Comments Off on (Update3) InterDigital 3rd Qtr profit nearly doubles on higher recurring licensing revenue lower expenses

Unwired Planet asks shareholders to ok reverse split and share reduction

Unwired Planet Inc. (UPIP), the patent licensing company run by CEO Boris Teksler, said it seeking permission from shareholders for a 1 for 20 reverse stock split and reduction in its shares outstanding from 1 billion shares to 250 million. The reverse-split and share reduction are board proposals disclosed today in a filing with the [...]

By | October 28th, 2015|Patent Investing|Comments Off on Unwired Planet asks shareholders to ok reverse split and share reduction

Rambus announces accelerated buyback program after disappointing earnings

Rambus Inc. (RMBS), the patent licensing company run by CEO Ron Black, on Monday announced it has initiated an accelerated share repurchase program with Citibank N.A. to repurchase an aggregate of approximately $100 million of its common stock, with an initial delivery of approximately 7,812,500 shares. The repurchase program was announced a week after the [...]

By | October 28th, 2015|Patent Investing|Comments Off on Rambus announces accelerated buyback program after disappointing earnings

ZTE wins invalidation of Dutch part of Vringo patent by Hague Court

The District Court of the Hague, the Netherlands, ruled today that the Dutch part of Vringo Inc.’s (VRNG) European Patent No 1,186,119 is invalid in a case filed by ZTE Corp.’s Dutch subsidiary in October 23, 2014. New York-based Vringo, the patent licensing company run by CEO Andrew Perlman, said it plans to appeal the [...]

By | October 28th, 2015|Patent Investing|Comments Off on ZTE wins invalidation of Dutch part of Vringo patent by Hague Court

(Update2) RPX posts 27.6% drop in 3rd Qtr net income on increase in revenue from smaller clients, higher than expected cost of revenue

RPX Corp. (RPXC), the patent aggregator and provider of litigation risk management services run by CEO John Amster, posted a 27.6% drop in net income in the third quarter of 2015 on an increase in smaller-sized clients and higher than expected cost of revenue. San Francisco-based RPX said its third quarter net income rose to [...]

By | October 27th, 2015|Patent Investing|Comments Off on (Update2) RPX posts 27.6% drop in 3rd Qtr net income on increase in revenue from smaller clients, higher than expected cost of revenue

(Update4) PTAB hands Bass and Spangenberg four more IPR institution wins against Celgene’s REMS ‘501, ‘720 patents and a denial against Biogen’s ‘393 patent

The Coalition for Affordable Drugs, the group controlled by billionaire J. Kyle Bass’s Hayman Capital Management and IP Navigation Group founder and owner Erich Spangenberg, won institution of four more inter partes review petitions, this time against Celgene Corp.’s patents. The decision on institution of IPR2015-01092, which concerned a pregnancy-prevention program for women prescribed a [...]

By | October 27th, 2015|Patent Investing|Comments Off on (Update4) PTAB hands Bass and Spangenberg four more IPR institution wins against Celgene’s REMS ‘501, ‘720 patents and a denial against Biogen’s ‘393 patent

DSS raises another $150K from share sales, may raise up to $2.02M by Oct. 30

Document Security Systems Inc. (DSS), the former patent licensing company trying to reinvent itself as a printer company, said it has raised $150,000 from the sale of 681,818 shares of common stock at a purchase price of 22 cents a share. The purchasers, who were not identified, also will receive four-year warrants to purchase up [...]

By | October 26th, 2015|Patent Investing|Comments Off on DSS raises another $150K from share sales, may raise up to $2.02M by Oct. 30

Vringo says new fliCharge unit expanded licensing pact with Bretford Manufacturing

Vringo Inc. (VRNG), the patent licensing company run by CEO Andrew Perlman, said its new fliCharge unit, which is acquired as part of the $6.33 million in preferred stock acquisition of International Development Group, has reached an agreement to extend and expand a license agreement with Bretford Manufacturing. The terms of the extended license were [...]

By | October 26th, 2015|Patent Investing|Comments Off on Vringo says new fliCharge unit expanded licensing pact with Bretford Manufacturing

PTAB hands Bass and Spangenberg’s second and third institution of IPRs, this time against Shire’s Gattex

The Coalition for Affordable Drugs, the group led by billionaire J. Kyle Bass’s hedge fund Hayman Capital Management, and IP Navigation Group founder and owner Erich Spangenberg, won institution of two petitions challenging a drug patent of Shire Plc. The ruling by the Patent Trial and Appeal Board in IPR2015-0090 and IPR2015-01093 involved U.S. Patent [...]

By | October 23rd, 2015|Patent Investing|Comments Off on PTAB hands Bass and Spangenberg’s second and third institution of IPRs, this time against Shire’s Gattex